316. Carnitine cycle disorder Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 10 - (DrugBank : 4) / Drug target genes : 2 - Drug target pathways : 11
Drugs and their primary sponsors and trial info
Bezafibrate
Rigshospitalet, Denmark
2009 Phase 2 NCT00983788 Denmark;
Bezafibrate (drug)
Assistance Publique - Hôpitaux de Paris
2006 Phase 3 NCT00336167 France;
Break in L-carnitine treatment
Karen Lindhardt Madsen
2013 - NCT02226419 -
Glycerol/Saline
Oregon Health and Science University
2016 - NCT02517307 United States;
Hyperinsulinemic euglycemic clamp
Oregon Health and Science University
2016 - NCT02517307 United States;
Intralipid/Heparin
Oregon Health and Science University
2016 - NCT02517307 United States;
Rigshospitalet, Denmark
2009 Phase 2 NCT00983788 Denmark;
Bezafibrate (drug)
Assistance Publique - Hôpitaux de Paris
2006 Phase 3 NCT00336167 France;
Break in L-carnitine treatment
Karen Lindhardt Madsen
2013 - NCT02226419 -
Glycerol/Saline
Oregon Health and Science University
2016 - NCT02517307 United States;
Hyperinsulinemic euglycemic clamp
Oregon Health and Science University
2016 - NCT02517307 United States;
Intralipid/Heparin
Oregon Health and Science University
2016 - NCT02517307 United States;